Acquisition of BlueRock Therapeutics by Bayer
BlueRock Therapeutics was acquired by Bayer for a reported $600 million.
All edits
BlueRocks Therapeutics was acquired by Bayed for a reported total of $600 million. The agreement between BayerBayer and BlueRock detailed an upfront payment of $240 million with $360 million in milestone payments over time.
BlueRocks Therapeutics was acquired by Bayed for a reported total of $600 million. The agreement between Bayer and BlueRock detailed an upfront payment of $240 million with $360 million in milestone payments over time.
Acquisition of BlueRock Therapeutics by Bayer
BlueRock Therapeutics was acquired by Bayer for a reported $600 million.
BlueRocks Therapeutics was acquired by Bayed for a reported total of $600 million. The agreement between Bayer and BlueRock detailed an upfront payment of $240 million with $360 in milestone payments over time.
Acquisition of BlueRock Therapeutics by Bayer
BlueRock Therapeutics was acquired by Bayer for a reported $600 million.
Find more entities like Acquisition of BlueRock Therapeutics by Bayer
